yangxin decoction

consists of astragalus, ginseng, poria with hostwood, angelica, ligusticum, zizyphus jujube, platycladi seed, schisandra, ginger, red jujube, dried tangerine peel, pinellia, polygalaceae, licorice, and spicy cinnamon; used for treatment of angina pectoris

Networked: 6 relevant articles (2 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Sun, Jing: 2 articles (05/2017 - 02/2013)
2.	Wang, Yan: 2 articles (05/2017 - 02/2013)
3.	Yu, Xiao-Hong: 2 articles (05/2017 - 02/2013)
4.	Zhou, Ya-Bin: 2 articles (05/2017 - 02/2013)
5.	Qian, Zhongyi: 1 article (09/2021)
6.	Yang, Qing: 1 article (09/2021)
7.	Li, Lan: 1 article (12/2018)
8.	Lu, Shu: 1 article (12/2018)
9.	Shen, Lijuan: 1 article (12/2018)
10.	Xing, Qingmin: 1 article (12/2018)

Related Diseases

1.	Coronary Disease (Coronary Heart Disease) 09/02/2022 - "This study assessed the effectiveness of Yangxin Decoction (YXD) in the treatment of coronary heart disease (CHD) patients with angina pectoris (AP). " 09/02/2022 - "Yangxin decoction for the treatment of angina pectoris of coronary heart disease: A systematic review of randomized controlled trial." 12/23/2022 - "There is no evidence-based data to confirm the efficacy of Yiqi Huoxue Yangxin Decoction combined with Western medicine in patients with coronary heart disease (CHD). " 12/23/2022 - "Efficacy and safety of Yiqi Huoxue Yangxin decoction combined with western medicine in patients with chronic coronary heart disease: A protocol for systematic review and meta-analysis."
2.	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 12/01/2018 - "Shenqi Yangxin decoction effectively reduced the dilated left ventricular diameter and improved heart function in dilated cardiomyopathy. " 12/01/2018 - "To investigate the effects of Shenqi Yangxin decoction (SQYXD) on heart function in a rat model of dilated cardiomyopathy (DCM) and its potential mechanisms. " 12/01/2018 - "Effect of Shenqi Yangxin decoction on high mobility group box 1 and inflammatory signal pathway in a rat model of dilated cardiomyopathy."
3.	Unstable Angina 02/01/2013 - "To primarily seek for unstable angina (UA) correlated metabolic markers and to observe the effects of Yangxin Decoction on the plasma metabolism of UA patients. " 02/01/2013 - "[Effects of yangxin decoction on metabolomics of patients with unstable angina]." 05/01/2017 - "This study aimed to explore the related metabolic biomarkers and to observe the effects of Yangxin Decoction (YXD) on plasma metabolism of patients with unstable angina (UA). " 05/01/2017 - "Biomarkers of unstable angina pectoris and yangxin decoction intervention: An exploratory metabonomics study of blood plasma."
4.	Angina Pectoris 09/02/2022 - "This study assessed the effectiveness of Yangxin Decoction (YXD) in the treatment of coronary heart disease (CHD) patients with angina pectoris (AP). " 09/02/2022 - "Yangxin decoction for the treatment of angina pectoris of coronary heart disease: A systematic review of randomized controlled trial."
5.	Heart Failure 09/01/2021 - "Impacts of Yangxin decoction on the expressions of MMP-9, CaN, NFAT3 and GATA4 in myocardial tissue of rats with chronic heart failure." 09/01/2021 - "To investigate the impacts of Yangxin decoction on the expressions of matrix metalloproteinase 9 (MMP-9), calcineurin (CaN), T cell activated nuclear factor 3 (NFAT3) and zinc finger transcription factor 4 (GATA4) in myocardial tissue of rats with chronic heart failure (CHF). "

Related Drugs and Biologics

1.	shenqi
2.	yiki-huoxue
3.	Biomarkers (Surrogate Marker)
4.	Matrix Metalloproteinase 9 (Gelatinase B)
5.	Calcineurin
6.	Transcription Factor 4